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1ST ASIA PACIFIC AKI CRRT 201710 years on burned patients with AKI started on RRT and found that
early RRT approach reduced mortality of burned patients with AKI.
Early RRT could halt the accumulation of toxic wastes that interfere
healing of burned wounds and affect hemodynamic stability of pa-
tients. RRT also allows better management of fluid, electrolytes and
acid-base balance. All these advantages could improve overall outcome
of burned patients with AKI.
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Introduction: ECMO (Extra Corporeal Membrane Oxygenation) is a
lifesaving modality for patients with severe organ dysfunction. The
incidence of Acute Kidney Injury (AKI) in such patients is very high.
Fluid overload is the single most important predictor of mortality in
such patients and Continuous Renal Replacement Therapy (CRRT) is the
preferred modality to manage it, alongwith AKI and metabolic distur-
bances. In India, ECMO with CRRT is a rarely used modality and very
few centers practice it.
Objective: To assess the experience of a tertiary care center in India of
combining ECMO with CRRT during the first 3 years of inception.
Method: We collected data retrospectively of 30 patients on ECMO
from Dec 2013 to Dec 2016 at our center. All data related to prevalence
of AKI (by AKIN criteria), indications, modality and access for RRT and
associated complications were collected. Outcome parameters like sur-
vival and net fluid balance were determined.
Results: Of the 30 cases, 18 (60%) underwent some form of RRT
while on ECMO. Nine patients (50%) each were on VenoArterial
(VA) and VenoVenous (VV) ECMO. Seven (38.9%) of these were on
RRT pre ECMO also. The commonest indication was AKI (88.8%, 16/
18), associated with metabolic acidosis(AKI+Met acidosis 66.7% (12/
18). Fluid overload was the second commonest indication(27.8% (5/
18). Independent access was commoner (12 cases; 66.7%) than access
via ECMO circuit for RRT 10(55.6%) cases. A CRRT device was used
in 7 and an inline hemofilter was used in 3 cases. In 4 cases, ECMO
circuit access was switched to independent access due to compli-
cations: 2 had damaged CRRT filter due to high pressure gradients;
one had recurrent clotting in CRRT circuit and one had ECMO pump
failure due to microbubbles in the circuit. One of the 5 overloaded
(20%) and one of 13 non overloaded patients survived (7.7%). Of 12
patients with met acidosis on RRT, acidosis was corrected in
8(66.7%): (of which 7 were weaned off ECMO; 2 survived). Mor-
tality rates were high on patients with CRRT and ECMO (16 of 18
cases, 88.9%) as compared to those without RRT (2 of 12; 16.7%).
The survivors on ECMO had a much less positive fluid balance than
non survivors.
Conclusions: The incidence of AKI was high (16/30 , 53.3%) in our
study and a majority required RRT. The associated mortality wasS38higher in these patients. Our study shows that CRRT is a safe technique
for maintenance of fluid and acid base balance. Independent access for
CRRT was found to be safer in our patients. Patients with less positive
fluid balance had a better survival.079
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Introduction: Patients on Extracorporeal Membrane Oxygenation
(ECMO) often have acute kidney injury or fluid overload requiring
Continuous Renal Replacement Therapy (CRRT). There was evidence
that ECMO patient requiring CRRT had higher mortality due to
increased severity of illness, but it is uncertain how CRRT affects
outcomes of ECMO patients.
Objectives: To explore the characteristics of ECMO survivors who
underwent concomitant CRRT.
Methodology: Retrospective chart review of 27 adult ECMO patients
with CRRT in a university-affiliated hospital in 2015 - 2016.
Results: 12 patients had veno-venous ECMO and 15 had veno-arterial
ECMO. Indications for ECMO were hypoxemic respiratory failure re-
fractory to conventional therapy, cardiogenic shock associated with
myocardial infarction, myocarditis and cardiac arrest. Mean age was
49.414.8 years. 9 ECMO-CRRT patients survived and 18 died. There
were more patients with primary respiratory diseases in survivor
group (77.8% vs 17.8%, p¼0.01). Similar findings were observed
between survivors and non-survivors for ECMO blood flow rate
(3.960.56 vs 3.50.6, p¼0.06), ECMO duration (16.714.1 vs
13.816.1, p¼0.64) and length of stay in intensive care unit (ICU)
(29.325.6 vs 15.017.0, p¼0.16). CRRT-ECMO configuration was the
same for all cases, except for one case in which CRRT was conducted
with non-tunneled dialysis catheter. Indications for CRRT treatment
included acute kidney injury, fluid overload and metabolic distur-
bance. 23 patients received systemic ECMO anticoagulation with
unfractionated heparin infusion at 12-18unit/kg/hour while 4 patients
in non-survivor group received regional citrate anticoagulation for
CRRT. Baseline creatinine before CRRT was 327.7233.9umol/L and
percentage creatinine change was 41.421.2%. CRRT treatment hours
(151.6191.1 hours), total fluid removal with CRRT (12.918.1 liters)
and number of hemofilter change (5.04.6) were not associated to
increase in mortality.
Conclusion: In this series of 27 patients managed with ECMO and
concomitant CRRT in an adult ICU, survival to ICU discharge was
33.3%. Mortality risk was increased in patients with circulatory failure
but not it was not associated with CRRT treatment modality.
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Introduction: Achieving optimal vancomycin dosing, particularly in
septic critically ill patients receiving continuous renal replacement
therapy (CRRT) is crucial. Established guidelines recommend the use
of trough concentrations to manage vancomycin dosing in adult
patients with gram-positive infections. Importantly, obtaining the
area under the plasma concentration-time curve (AUC), based on the
pharmacokinetic / pharmacodynamics (PK/PD) concept, is extremely
required.
Objective: This study aimed to describe the pharmacokinetics (PK) of
vancomycin in Malaysian critically ill patients receiving CRRT, and the
achievement of its therapeutic target, the ratio of the AUC to the
minimum inhibitory concentration (MIC) of causative pathogen (AUC/
MIC >400), using a standard dosing regimen (750 mg 12 hourly).
Methodology: This was a prospective PK study of vancomycin using
standard dosing regimen, in critically ill patients receiving continuous
venovenous haemofiltration (CVVH). Blood samples were collected at
ten sampling times during a dosing interval. PK analyses were evalu-
ated using non-compartmental method. Vancomycin trough concen-
trations (15-20 mg/L), and the achievement of the ratio of AUC/
MIC>400, based on selected susceptibility breakpoint (MIC¼1 mg/L),
were evaluated.
Results: Fifty blood samples from five PK profiles of five patients were
analysed. The median (interquartile range) of vancomycin total clear-
ance (CLtotal) and volume of distribution (Vd) were 62.8 (45.1-62.7) mL/
min and 62.0 (48.7-94.2) L respectively, during CVVH. Maximum
concentration, Cmax[30.8 (30.5-33.2) mg/L] was observed at 1.80.3 h.
The standard dosing regimen (750 mg 12 hourly) resulted in AUC0-24
and Cmin of 400.1 (399.0-504.1) mg.h/L and 12.1 (10.7-16.1) mg/L,
respectively. Of these, only two patients, who were anuric, obtained
trough concentration between 15-20 mg/L and subsequently achieved
the targeted AUC/MIC>400 (MIC¼1 mg/L).
Conclusion: Obtaining trough concentration between 15-20 mg/L rela-
tively achieved the desired AUC/MIC >400 for vancomycin during
CVVH. Higher trough concentration (e.g 20-25 mg/L) may be required
when targeting for a higher MIC (e.g >1mg/L). Initiation of a
higher dosing regimen could also be necessary, particularly in patients
undergoing CVVH with significant residual native renal function. Further
data is required, from continuation of this study, to clarify the findings.
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Introduction: The number of patients requiring renal replacement
therapy (RRT) due to acute kidney injury (AKI) is increasing in trend.
AKI carries high morbidity and mortality, increases overall medical cost
and results in longer inpatient stay.
Objective: To describe CCN service in a tertiary hospital setting by
analyzing admissions that required RRT and factors influencing their
outcome.
Methodology: Patients in intensive care unit (ICU), cardiac care unit
(CCU), cardiothoracic intensive care unit (CICU) and cardiac high de-
pendency ward (CHDW) requiring RRT from 2006 to 2016 was
included, with data from our electronic Hospital Information System
(eHIS). Patients whom developed AKI were described in detail.
The team consists of 1 nephrologist, 1 nephrology trainee, 2 medical
officers and 2 HD staff. We are equipped with 4 continuous renal
replacement therapy (CRRT) machines (2 Prismaflex, 2 Aquarious), 1
Fresenius sustained low efficiency daily diafiltration (SLEDD)
machine and 4 Fresenius HD machines. Our comprehensive CCN service
is well-structured, right from the initial renal referral and consult,
decision on RRT, venous access insertion, initiation of RRT and sub-
sequent RRT related monitoring and management.Kidney International Reports (2017) 2, S1–S41Results: Outpatient HD has grown from 9059 to 14775 and acute RRT
increased from a mere 99 to 938. In 2016 alone, 258 patients required
RRT, out of which 76 were end stage renal disease(ESRD) patients and
182 patients with a mean age of 52.1 16.0 developed AKI in the
intensive care setting and required RRT. A total of 867 procedures was
performed; 55.5% CRRT, 27.5% SLEDD and 17% HD. 59.3% of pa-
tients were admitted in ICU. The rest were in CCU (18.7%), CICU
(18.7%) and CHDW (1.6%). Femoral vein catheter (FVC) was the
preferred vascular access, with 99% (180) insertions and 2 internal
jugular catheters (IJC). Some patients required more than one catheter
insertion due to prolonged stay and continued RRT requirement. Pa-
tients with sepsis and multi organ dysfunction (MOD) were more likely
to be on CRRT. Mortality rate in that group was higher at 64%. A
significant number of these patients were diabetic (p¼0.031).
Conclusion: There has been a tenfold increase in the number of acute RRT
procedures performed over the past 10 years. However this tremendous
rise has not been matched by a mere increase from 10 to 20 dialysis staff
throughout this period. As AKI is a common complication in critically ill
patients, efficient and prompt critical care nephrology treatment is of
utmost importance in ensuring better outcome for patients.
067
AN ANALYSIS OF FIXED VERSUS
ADJUSTABLE DOSING IN CONTINUOUS RENAL
REPLACEMENT THERAPY IN CRITICALLY ILL
PATIENTS WITH ACUTE KIDNEY INJURY
Arbaei, Nabilah Che1, Mohd, Aida Madiha1, Hasan, Hasni Muniati2,
Najibah, Nik3, Halimi, Wan Hasnul1, Rapiah, Zuad Firdaus1
1Department of Nephrology, 2Clinical Research Center(CRC), 3Department
of Pharmacy, Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan,
Malaysia
Category: RRT Technique Characteristics
Presenter: Dr WAN HASNUL HALIMI WAN HASSAN
Keywords: CRRT, AKI, Fixed CRRT dosing, Adjustable CRRT dosing,
outcome
Introduction: Fixed CRRT dosing between 20-35 ml/kg/hr has been
shown effective and improves renal function an reduced mortality.
Locally, we will adjust the CRRT dosing periodically depending on the
patient’s response.
Methods: This retrospective study was conducted in a general hospital
in Kelantan, Malaysia. Medical records of all patients admitted to ICU
from January 2016 to March 2017 with diagnosis of AKI were reviewed
for inclusion criteria. All critically ill adults patient (>18 years old)
diagnosed with AKI with any types of CRRT and completed at least 48
hours treatment were enrolled in this study.
It was considered to be fixed dose of CRRT if the patient received a
fixed dosing throughout the treatment and adjustable dose if, at any
time, the managing physician alter the dosing on intention-to- treat basis.
The data was analysed using IBM SPS statistics version 20.0 for
Windows software. A p value of <0.05 was considered statistically
significant.
Results: A total of 24 critically ill patients with acute kidney injury
(AKI) were included in the analysis after considering inclusion andS39
